Bergasa NV - Search Results

1

Primary biliary cirrhosis: report of a focus study group.

Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Bergasa NV, et al. Hepatology. 2004 Oct;40(4):1013-20. doi: 10.1002/hep.20446. Hepatology. 2004. PMID: 15382160 Review. No abstract available.

2

A study of the mu opioid receptor gene polymorphism A118G in patients with primary biliary cirrhosis with and without pruritus.

Wei LX, Floreani A, Variola A, El Younis C, Bergasa NV. Wei LX, et al. Among authors: bergasa nv. Acta Derm Venereol. 2008;88(4):323-6. doi: 10.2340/00015555-0436. Acta Derm Venereol. 2008. PMID: 18709298 Free article.

3

A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus.

Floreani A, Carderi I, Variola A, Rizzotto ER, Nicol J, Bergasa NV. Floreani A, et al. Among authors: bergasa nv. Hepatology. 2006 May;43(5):1152-4. doi: 10.1002/hep.21165. Hepatology. 2006. PMID: 16628674

4

Sleep-Wake profiles in patients with primary biliary cirrhosis.

Montagnese S, Nsemi LM, Cazzagon N, Facchini S, Costa L, Bergasa NV, Amodio P, Floreani A. Montagnese S, et al. Among authors: bergasa nv. Liver Int. 2013 Feb;33(2):203-9. doi: 10.1111/liv.12026. Epub 2012 Nov 22. Liver Int. 2013. PMID: 23173839

5

Primary biliary cirrhosis.

Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Lindor KD, et al. Among authors: bergasa nv. Hepatology. 2009 Jul;50(1):291-308. doi: 10.1002/hep.22906. Hepatology. 2009. PMID: 19554543 Free article. No abstract available.

6

Blood-brain barrier permeability is markedly decreased in cholestasis in the rat.

Wahler JB, Swain MG, Carson R, Bergasa NV, Jones EA. Wahler JB, et al. Among authors: bergasa nv. Hepatology. 1993 Jun;17(6):1103-8. Hepatology. 1993. PMID: 8514260

7

Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis.

Floreani A, Lazzari R, Macchi V, Porzionato A, Variola A, Colavito D, Leon A, Guido M, Baldo V, De Caro R, Bergasa NV. Floreani A, et al. Among authors: bergasa nv. J Gastroenterol. 2010;45(1):68-76. doi: 10.1007/s00535-009-0122-y. J Gastroenterol. 2010. PMID: 19730968

8

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.

Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, Jenkins JB, Jones EA. Bergasa NV, et al. Hepatology. 1998 Mar;27(3):679-84. doi: 10.1002/hep.510270307. Hepatology. 1998. PMID: 9500694 Clinical Trial.

9

Central mu-opioid receptors are down-regulated in a rat model of cholestasis.

Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA. Bergasa NV, et al. J Hepatol. 1992 May;15(1-2):220-4. doi: 10.1016/0168-8278(92)90040-v. J Hepatol. 1992. PMID: 1324272

10

A pilot study of ribavirin therapy for chronic hepatitis C.

Di Bisceglie AM, Shindo M, Fong TL, Fried MW, Swain MG, Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Hoofnagle JH. Di Bisceglie AM, et al. Among authors: bergasa nv. Hepatology. 1992 Sep;16(3):649-54. doi: 10.1002/hep.1840160307. Hepatology. 1992. PMID: 1505907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters